Bradykinin Potentiator C, Angiotensin I Converting Enzyme Inhibitor is a venom-derived peptide known for interacting with metallopeptidase pathways. Its sequence architecture permits examination of enzyme-binding determinants and substrate protection. Researchers employ it to dissect kinin pathway modulation. The peptide provides insight into structural signatures of inhibitory venom peptides.
CAT No: B09002
CAS No:30953-20-9
Synonyms/Alias:Bradykinin Potentiator C, Angiotensin I Converting Enzyme Inhibitor;
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More